Top Biotechnology Startups in 2024

TrialSpark is transforming the way new medical treatments are brought to market. We’re a technology company that runs end-to-end clinical trials through a network of our own TrialSpark-operated trial sites, making the entire lifecycle of clinical trials more efficient, accessible, and patient-centric. We're growing quickly and would love to have you join us!

Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, and the household goods that we rely on every day. But moving at the new speed of science requires better technology. Benchling’s mission is to unlock the power of biotechnology. The world’s most innovative biotech companies use Benchling’s R&D Cloud to power the development of breakthrough products.

Apeel uses materials that exist in the peels, seeds, and pulp of all fruits and vegetables to create a protective extra peel that seals moisture in and keeps oxygen out. That means our produce stays fresh, nutritious, and delicious twice as long. It also means less produce goes to waste throughout the supply chain—from grower to retailer to consumers at home. Less waste for you means less waste for the planet and a more abundant future for us all.

Quartzy is the world’s leading lab management solution for small- and medium-sized R&D organizations. Customers can manage their inventory, streamline purchasing communications, and consolidate ordering all in one place. Thousands of labs at pharmaceutical/biotechnology companies as well as hospitals hospitals and academic centers use Quartzy every day improve their requisitioning and procurement processes. Because the requisitioning process is linked to the Quartzy inventory, users know exactly where things are and when to order more. Quartzy also adds value to the suppliers in this large market by helping them reach their customers more effectively. This combination of a software platform plus a digital distributor results in a powerful and extremely convenient user experience that helps researchers focus on their research and accelerates the pace of scientific discovery.

H1 was built by scientists for scientists. We empower stakeholders at healthcare and life science companies to make smarter scientific decisions by providing access to critical data through an intuitive interface. Working with some of the largest and most influential global life science organizations, H1 provides insight into thought leaders, scholarly content, academics, and healthcare professionals with much more on the way.

Color makes data-driven health programs such as clinical genetics accessible, convenient, and cost-effective for everyone. Color partners with leading health systems, premier employers, and national health initiatives around the world including the million-person All of Us program by the National Institutes of Health. Rock Health has recognized Color as the “Best Digital Health Company to Work For.” We are committed to building an inclusive and diverse team that helps make precision health programs accessible, convenient, and cost effective for everyone. For more information about Color, visit color.com.

Q Bio is revolutionizing primary care with the first clinical digital twin platform, powered by breakthrough whole-body scanning technology, that highlights the most important changes in a person’s physiology for sharing with physicians and specialists anywhere in the world. The company was founded in 2015 and is headquartered in San Carlos, California. Q Bio was founded by Jeffrey Kaditz, serial entrepreneur and Founder of Affirm, Dr Michael Snyder, Chair of Genetics and Director of Personalized Medicine and Stanford University, and Dr Garry Choy, physician, radiologist, and former Chief Medical Information Officer at Mass General Hospital. We are fortunate to be backed by some of the best venture groups in the world including: A16Z, Khosla Ventures, Founders Fund, SciFi VC, and Kevin Durant.

Founded to improve lives with high-value care, hc1 has emerged as the bioinformatics leader in precision testing and prescribing. The cloud-based hc1 Platform organizes live data, including lab results, genomics, and medications, to deliver solutions that ensure the right patient gets the right test and the right prescription. Today, the hc1 Platform powers two flagship solutions hc1 Lab CRM and hc1 Test Utilization™, as well as breakthrough precision prescribing innovations hc1 Opioid Advisor™ and hc1 PGx Advisor™. To learn more about hc1’s proven approach to personalizing care while eliminating waste for thousands of health systems, diagnostic laboratories, and health plans, visit hc1.com and follow us on Twitter, Facebook, and LinkedIn.

BenchSci's vision is to bring medicine to patients 50% faster by 2025. The company empowers scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science at 15 top 20 pharmaceutical companies and over 4,300 leading research centers worldwide. BenchSci is a CIX Top 10 Growth company, certified Great Place to Work®, and top-ranked company on Glassdoor.

Second Order Effects (SOE) is a California-based engineering firm specializing in custom electronics and end-to-end electronic system design. We develop cross-disciplined solutions and products to solve some of the world’s most challenging problems by optimizing solutions beyond the first order. SOE tackles a wide range of projects in the aerospace, automotive, industrial, and commercial sectors. We design and build flight control systems, wireless communication devices, power electronics, analog sensor interfaces, mixed-signal circuits, motor drivers, system controllers, video cameras, embedded computers, and optical and RF amplifiers, sensors, and antennas. Our designs have gone into rocket engines, satellites, self-driving cars, automated systems, and household/retail consumer electronics.